Which bacterial biofilm exopolysaccharide is preferred, psl or alginate?

Journal of Bacteriology

Volumn 195, Issue 8, 2013, Pages 1623-1626

  Schurr, Michael J ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; BACTERIAL POLYSACCHARIDE; CYCLIC AMP BINDING PROTEIN; DNA BINDING PROTEIN; EXOPOLYSACCHARIDE; GLUCOSE; GUANYLATE CYCLASE; INTEGRATION HOST FACTOR; MANNOSE; PSL; RHAMNOSE; UNCLASSIFIED DRUG;

BACTERIAL COLONIZATION; BACTERIUM ISOLATE; BINDING SITE; BIOFILM; BIOINFORMATICS; BROTH DILUTION; CELL VIABILITY; GENE CLUSTER; GENE DELETION; LUNG FIBROSIS; NONHUMAN; NOTE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PSEUDOMONAS AERUGINOSA; SECOND MESSENGER; TRANSCRIPTION REGULATION; TWITCHING MOTILITY; TYPE III SECRETION SYSTEM;

BACTERIAL PROTEINS; BIOFILMS; GENE EXPRESSION REGULATION, BACTERIAL; PSEUDOMONAS AERUGINOSA; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

BACTERIA (MICROORGANISMS);

EID: 84876071294     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00173-13     Document Type: Note

References (34)

1. Jones CJ, Ryder CR, Mann EE, Wozniak DJ. 2013. AmrZ modulates Pseudomonas aeruginosa biofilm architecture by directly repressing transcription of the psl operon. J. Bacteriol. 195:1637-1644.
2. Wozniak DJ, Wyckoff TJ, Starkey M, Keyser R, Azadi P, O'Toole GA, Parsek MR. 2003. Alginate is not a significant component of the extracellular polysaccharide matrix of PA14 and PAO1 Pseudomonas aeruginosa biofilms. Proc. Natl. Acad. Sci. U. S. A. 100:7907-7912.
3. Friedman L, Kolter R. 2004. Genes involved in matrix formation in Pseudomonas aeruginosa PA14 biofilms. Mol. Microbiol. 51:675-690.
4. Friedman L, Kolter R. 2004. Two genetic loci produce distinct carbohydrate-rich structural components of the Pseudomonas aeruginosa biofilm matrix. J. Bacteriol. 186:4457-4465.
5. Govan JR, Deretic V. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60:539-574.
6. Doggett RG. 1969. Incidence of mucoid Pseudomonas aeruginosa from clinical sources. Appl. Microbiol. 18:936-937.
7. Jackson KD, Starkey M, Kremer S, Parsek MR, Wozniak DJ. 2004. Identification of psl, a locus encoding a potential exopolysaccharide that is essential for Pseudomonas aeruginosa PAO1 biofilm formation. J. Bacteriol. 186:4466-4475.
8. Matsukawa M, Greenberg EP. 2004. Putative exopolysaccharide synthesis genes influence Pseudomonas aeruginosa biofilm development. J. Bacteriol. 186:4449-4456.
9. Franklin MJ, Nivens DE, Weadge JT, Howell LP. 2011. Biosynthesis of the Pseudomonas aeruginosa extracellular polysaccharides alginate, Pel, and Psl. Front. Microbiol. 2:167. doi:10.3389/fmicb.2011.00167.
10. Hay ID, Rehman ZU, Ghafoor A, Rehm BH. 2010. Bacterial biosynthesis of alginates. J. Chem. Technol. Biotechnol. 85:752-759.
11. Mathee K, Kharazmi A, Hoiby N. 2002. Role of exopolysaccharide in biofilm matrix formation: the alginate paradigm, p 1-34. In McLean RJC, Decho AW (ed), Molecular ecology of biofilms. Horizon Scientific Press, Wymondham, United Kingdom.
12. Muhammadi Ahmed N. 2007. Genetics of bacterial alginate: alginate genes distribution, organization and biosynthesis in bacteria. Curr. Genomics 8:191-202.
13. Pritt B, O'Brien L, Winn W. 2007. Mucoid Pseudomonas in cystic fibrosis. Am. J. Clin. Pathol. 128:32-34.
14. Cochran WL, Suh SJ, McFeters GA, Stewart PS. 2000. Role of RpoS and AlgT in Pseudomonas aeruginosa biofilm resistance to hydrogen peroxide and monochloramine. J. Appl. Microbiol. 88:546-553.
15. Hentzer M, Teitzel GM, Balzer GJ, Heydorn A, Molin S, Givskov M, Parsek MR. 2001. Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function. J. Bacteriol. 183:5395-5401.
16. Byrd MS, Pang B, Hong W, Waligora EA, Juneau RA, Armbruster CE, Weimer KE, Murrah K, Mann EE, Lu H, Sprinkle A, Parsek MR, Kock ND, Wozniak DJ, Swords WE. 2011. Direct evaluation of Pseudomonas aeruginosa biofilm mediators in a chronic infection model. Infect. Immun. 79:3087-3095.
17. Boucher JC, Schurr MJ, Deretic V. 2000. Dual regulation of mucoidy in Pseudomonas aeruginosa and sigma factor antagonism. Mol. Microbiol. 36:341-351.
18. Martin DW, Schurr MJ, Yu H, Deretic V. 1994. Analysis of promoters controlled by the putative sigma factor AlgU regulating conversion to mucoidy in Pseudomonas aeruginosa: relationship to sigma E and stress response. J. Bacteriol. 176:6688-6696.
19. Wozniak DJ, Sprinkle AB, Baynham PJ. 2003. Control of Pseudomonas aeruginosa algZ expression by the alternative sigma factor AlgT. J. Bacteriol. 185:7297-7300.
20. Amikam D, Galperin MY. 2006. PilZ domain is part of the bacterial c-di-GMP binding protein. Bioinformatics 22:3-6.
21. Merighi M, Lee VT, Hyodo M, Hayakawa Y, Lory S. 2007. The second messenger bis-(3=-5=)-cyclic-GMP and its PilZ domain-containing receptor Alg44 are required for alginate biosynthesis in Pseudomonas aeruginosa. Mol. Microbiol. 65:876-895.
22. Remminghorst U, Rehm BH. 2006. Alg44, a unique protein required for alginate biosynthesis in Pseudomonas aeruginosa. FEBS Lett. 580:3883-3888.
23. Mathee K, Ciofu O, Sternberg C, Lindum PW, Campbell JI, Jensen P, Johnsen AH, Givskov M, Ohman DE, Molin S, Hoiby N, Kharazmi A. 1999. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology 145:1349-1357.
24. Bragonzi A, Worlitzsch D, Pier GB, Timpert P, Ulrich M, Hentzer M, Andersen JB, Givskov M, Conese M, Doring G. 2005. Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model. J. Infect. Dis. 192:410-419.
25. Galperin MY, Gaidenko TA, Mulkidjanian AY, Nakano M, Price CW. 2001. MHYT, a new integral membrane sensor domain. FEMS Microbiol. Lett. 205:17-23.
26. Wood SR, Firoved AM, Ornatowski W, Mai T, Deretic V, Timmins GS. 2007. Nitrosative stress inhibits production of the virulence factor alginate in mucoid Pseudomonas aeruginosa. Free Radic. Res. 41:208-215.
27. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T, Botzenhart K, Yankaskas JR, Randell S, Boucher RC, Doring G. 2002. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109:317-325.
28. Hay ID, Remminghorst U, Rehm BH. 2009. MucR, a novel membraneassociated regulator of alginate biosynthesis in Pseudomonas aeruginosa. Appl. Environ. Microbiol. 75:1110-1120.
29. Albus AM, Pesci EC, Runyen-Janecky LJ, West SE, Iglewski BH. 1997. Vfr controls quorum sensing in Pseudomonas aeruginosa. J. Bacteriol. 179: 3928-3935.
30. Beatson SA, Whitchurch CB, Sargent JL, Levesque RC, Mattick JS. 2002. Differential regulation of twitching motility and elastase production by Vfr in Pseudomonas aeruginosa. J. Bacteriol. 184:3605-3613.
31. Dasgupta N, Ferrell EP, Kanack KJ, West SE, Ramphal R. 2002. fleQ, the gene encoding the major flagellar regulator of Pseudomonas aeruginosa, is sigma70 dependent and is downregulated by Vfr, a homolog of Escherichia coli cyclic AMP receptor protein. J. Bacteriol. 184:5240-5250.
32. Wolfgang MC, Lee VT, Gilmore ME, Lory S. 2003. Coordinate regulation of bacterial virulence genes by a novel adenylate cyclase-dependent signaling pathway. Dev. Cell 4:253-263.
33. DeVault JD, Hendrickson W, Kato J, Chakrabarty AM. 1991. Environmentally regulated algD promoter is responsive to the cAMP receptor protein in Escherichia coli. Mol. Microbiol. 5:2503-2509.
34. Okkotsu Y, Pritchett CL, Schurr MJ. 2013. Regulation of exopolysaccharide biosynthesis in Pseudomonas aeruginosa, p 176. In Vasil ML, Darwin AJ (ed), Regulation of bacterial virulence. ASM Press, Washington, DC.